Migraine In America 2019

Survey Finds Positive HCP Relationships, Negative Quality of Life for Chronic Migraine Patients Who Currently Vs. Never Used CGRP

A new survey from Health Union, Migraine In America 2019, finds that people with chronic migraine who currently use a treatment to target calcitonin-gene-related peptides (CGRP) are more likely than those who have never used CGRP therapies to have positive relationships with their healthcare professionals (HCPs) but negative quality of life. The survey illuminates the perspectives and experiences of people impacted by migraine.


Diabetes Burnout

Understanding Diabetes Burnout: What Pharma Can Learn To Help People Better Manage Type 2 Diabetes

Recent Health Union survey data of 2,142 people living with type 2 diabetes showed that 58% of respondents indicated they have experienced burnout related to their condition. Understanding the variety of real-world implications of diabetes burnout can help pharma impact people during critical points of their patient journey--and also reach the people who may be involved in that patient’s care, as well.


Health Union Announces Multiple Presentations at APHA 2019 Annual Meeting and Expo

Health Union will share research findings based on data and experience from three of the company’s oncology-specific online health communities in presentations at the American Public Health Association (APHA) 2019 Annual Meeting and Expo in Philadelphia.


MM&M – Infographic: Do patients actually watch all those pharma TV ads? (Findings from Media Habits Survey)

Practical Neurology – Survey Shows People With Chronic Migraine Released, Includes Information on Use of CGRP-Related Treatments (Migraine In America 2019 Findings)

PM360 – PM360 2019 Innovative Service: Condition Explorer from Health Union

The Philadelphia Inquirer – With Alzheimer’s, the Phone Can Be Both a Lifeline And a Danger ( Advocate Jim Klunder)

RT Magazine – Survey: Cystic Fibrosis Patients Receiving CFTR Modulators Had More Positive Health Outlooks (Cystic Fibrosis In America 2019 Findings)

PharmaVOICE – Patient Influencers Are Transforming Pharma Marketing Strategies (Olivier Chateau, co-founder & CEO)

PharmaVOICE – A Crisis of Trust: Pharma’s Battle to Win Back Public Confidence (Lauren Lawhon, COO)

PharmaVOICE – The Changing Role of the Traditional Pharma Brand (Olivier Chateau, co-founder & CEO)

PharmaVOICE – The Future of Decentralized Trials (Lauren Lawhon, COO)

PharmaVOICE – Bringing Humanity Back to Healthcare (Olivier Chateau, co-founder & CEO)

PM360 – Four Key Questions About Data Analytics in 2019 (David Shronk, SVP, Media)

Philadelphia Business Journal – 7 Philadelphia-Area Companies Make Deloitte Fastest-Growing List Philly – These 4 Philly Companies Were Named to Deloitte’s Technology Fast 500 List

Practical Dermatology – Poll: People Who Developed AD Symptoms as Kids Experience More Severe Symptoms (Atopic Dermatitis In America 2019 Findings)

Philadelphia Magazine – For His 30th Birthday, This Leukemia Survivor Went on a Road Trip to Share His Story in 30 Cities ( Advocate Vincent Goodwin)

Outsourcing Pharma – BBK Report: Design, Content Are Key to Health App Usage (Health Union Survey Partnership)

PharmaVOICE – Digital Pharma East with David Shronk (Video)

PM360 – Healthcare Watch October 2019 – Women with Endometriosis: Hormone Shopping (Endometriosis In America 2019 Findings)

Multiple Sclerosis News Today – RRMS Patients Not Using DMTs More Likely to Have Been Misdiagnosed, Cite Poorer Relationships with Doctors, Survey Says (MS In America 2019 Findings)

American Journal of Managed Care – Digital Inhaler Interest Growing Among Patients With Severe Forms of COPD or Asthma (COPD & Asthma In America 2019 Findings)